As a potential mechanism, it has been proposed that reduced levels of SLC6A2 lead to dysfunction of serotonergic system by inhibiting serotonin uptake, which in turn may increase the susceptibility to depression [111]. Here, SLC6A2 is linked to depressive symptom measurement.